David Pépin, PhD, Oviva Therapeutics, and Granata Bio featured in Time magazine series on The Age of Longevity

Written By Sarah Faranda

A recent Time magazine feature on longevity explains why the science of ovarian aging is no longer optional reading. “Ovaries Could Unlock Secrets of Longevity” highlights the work David Pépin, PhD, is doing with Oviva Therapeutics, a Granata Bio company. Read the article here.

Sarah Faranda
Next

Zeb Younes, Chief Regulatory Officer, CMC at Granata Bio, featured in the January 2026 issue of Regulatory Rapporteur